NICE Enough? Watchdog's Basic Approach Is Sound, But More Transparency Is Urged

An independent report into how NICE values medicines concludes that the basis of its cost-effectiveness assessment is sound, but can be improved. And more transparency would help.

More from Archive

More from Pink Sheet